Moneycontrol PRO
Loans
Loans
HomeNewsIndiaAs India completes one month of COVID-19 vaccination, here is all one needs to know

As India completes one month of COVID-19 vaccination, here is all one needs to know

The process of jabbing needs to be fastened. On an average, about three lakh people are being inoculated every day against a government target of 13 lakh

February 15, 2021 / 17:44 IST

India had launched its COVID-19 vaccination drive on January 16. In the initial phase, three crore healthcare and frontline workers across the country are being inoculated.

India deployed two COVID-19 vaccines for the rollout; one is Serum Institute of India’s (SII) Covishield and the other is Bharat Biotech's, Covaxin. While Covishield was given restricted emergency use approval (EUA) by the government, Covaxin was allowed EUA on clinical trial mode, as the vaccine hasn't yet submitted the Phase-3 efficacy data. Both the vaccines have to be given in two doses.

India reported 10.8 million Covid-19 cases, with a recovery rate of around 97 percent, which is one of the highest in the world.

Here is an explainer on where India stands in terms of vaccination numbers; details about the second dose; has India overcome vaccine hesitancy and what are the challenges in the way of increasing vaccination speed?

How many people have been vaccinated so far?

India has vaccinated 8.3 million healthcare and frontline workers, as on February 15. About three-fourths of those injected include healthcare workers, while the rest are frontline workers. The nationwide coverage of COVID-19 vaccination for healthcare workers was 60 percent. The vaccination of frontline workers, which began on February 1, was able to cover 11 percent of the targeted two crore. The government has said it will inoculate about one crore healthcare workers in the first phase. This will be followed by jabbing two crore frontline workers, including police, the armed forces, municipal workers and revenue staff.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Which states and Union Territories are ahead in vaccination coverage and who are the laggards in the first phase? Bihar achieved the highest COVID-19 vaccine coverage of healthcare workers at 80.6 percent, followed by Tripura (78.9 percent), Odisha (76.7 percent), Madhya Pradesh (75.8 percent), Uttarakhand (74.8 percent), Himachal Pradesh (74.5 percent), Chhattisgarh (73 percent), Kerala (71.1 percent) and Rajasthan (70.7 percent). Among the Union Territories - Lakshadweep has the highest coverage of 81 percent. The states that are lagging behind include Meghalaya (37.2 percent), Manipur (37 percent), Punjab (36.4 percent), Tamil Nadu (33.9 percent) and Nagaland (23 percent). The Union Territories with the lowest coverage are Chandigarh (32.1 percent) and Puducherry (19.9 percent).

When will the second dose of inoculation begin?

The second dose of vaccination for beneficiaries, who have completed 28 days after receipt of the first shot, began on February 13. The approval provided by the Drug Controller General of India (DCGI), accords a window of four to six weeks for the second dose. So far 24,561 healthcare workers have received the second jab. Vaccination is said to be complete only if the beneficiary has received two doses. Antibodies against vaccines will develop about 14 days after the second shot.

When will vaccination begin for those over 50 years and persons with co-morbidity?

The third phase, in which the government plans to inoculate 27 crore people above 50 years of age and those with co-morbidity like diabetes, hypertension, and organ transplant patients, will begin in March 2021.

What about the CoWIN glitches?

CoWIN - the digital backbone of the COVID-19 vaccination in India - has largely stabilized. The platform was plagued with technical glitches during the initial days of vaccination, delaying the rollout in several places. While most problems have been sorted out, complaints like duplication of names, beneficiaries not receiving SMS, and details of their vaccination slots, continue. With vaccination for the 50-plus set to begin, the platform will come under increasing scrutiny.

Is vaccine hesitancy on the wane?

Vaccine hesitancy among healthcare workers is the possible reason behind the low coverage of COVID-19 vaccination in many states. Fears of vaccine-induced side effects, the waning pandemic and the 'wait and watch' approach for more COVID-19 vaccine options, has kept many healthcare workers away from getting inoculated. In many hospitals, the heads of departments are leading the way by taking the vaccine. Some hospitals have also organised counselling sessions with senior doctors, putting up 'selfie-points' where those who get vaccinated can take photos and upload them on social media. All these are done with an eye on nudging hesitant healthcare workers to bite the bullet.

What about serious adverse reactions during the last month?

Government figures say that a mere 0.0004 percent were hospitalised against vaccinations, which is negligible. As of February 13, there were 34 hospitalisations, of which 21 were discharged, two were under treatment and 11 passed away.

Which vaccines are deployed the most?

The Covishield vaccine is being used widely. The government through HLL Lifecare Limited bought 11 million doses of Covishield from Serum Institute at Rs 200 per dose, 3.85 million doses at Rs 295 per dose and 1.65 million doses at no cost of Covaxin from Bharat Biotech. The government purchased an additional 1 crore doses from SII at Rs 210 per dose. It is committed to buy 4.5 crore doses in the initial phase.

Is there a need for increasing the speed of vaccination? Yes. On an average, India is inoculating about three lakh people per day, which is way short of the government's target of 13 lakh people a day! At the current pace, it will take two-and-a-half years to inoculate the entire population with two doses of the vaccine. The government needs to step up speed to ensure that at least the most vulnerable segment of the population is vaccinated as fast as possible, in the backdrop of the virus mutating and threatening to reduce the impact of the existing vaccines.

Viswanath Pilla
Viswanath Pilla is a business journalist with 14 years of reporting experience. Based in Mumbai, Pilla covers pharma, healthcare and infrastructure sectors for Moneycontrol.
first published: Feb 15, 2021 05:42 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347